Elevation Oncology, Inc. (NASDAQ:ELEV – Get Free Report) was the target of a significant drop in short interest in July. As of July 15th, there was short interest totalling 1,320,000 shares, a drop of 11.4% from the June 30th total of 1,490,000 shares. Based on an average daily volume of 1,940,000 shares, the short-interest ratio […]